{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:45:40Z","timestamp":1792532740453,"version":"4.5.0"},"reference-count":150,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministerium f\u00fcr Kultur und Wissenschaft des Landes Nordrhein-Westfalen","award":["161L0271"],"award-info":[{"award-number":["161L0271"]}]},{"name":"Berliner Senatsverwaltung f\u00fcr Wissenschaft, Gesundheit und Pflege","award":["161L0271"],"award-info":[{"award-number":["161L0271"]}]},{"name":"Federal Ministry of Education and Research (Bundesministerium f\u00fcr Bildung und Forschung, BMBF)","award":["161L0271"],"award-info":[{"award-number":["161L0271"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The primary prevention, early detection, and treatment of cardiovascular disease (CVD) have been long-standing scientific research goals worldwide. In the past decades, traditional blood lipid profiles have been routinely used in clinical practice to estimate the risk of CVDs such as atherosclerotic cardiovascular disease (ASCVD) and as treatment targets for the primary prevention of adverse cardiac events. These blood lipid panel tests often fail to fully predict all CVD risks and thus need to be improved. A comprehensive analysis of molecular species of lipids and metabolites (defined as lipidomics and metabolomics, respectively) can provide molecular insights into the pathophysiology of the disease and could serve as diagnostic and prognostic indicators of disease. Mass spectrometry (MS) and nuclear magnetic resonance (NMR)-based lipidomics and metabolomics analysis have been increasingly used to study the metabolic changes that occur during CVD pathogenesis. In this review, we provide an overview of various MS-based platforms and approaches that are commonly used in lipidomics and metabolomics workflows. This review summarizes the lipids and metabolites in human plasma\/serum that have recently (from 2018 to December 2022) been identified as promising CVD biomarkers. In addition, this review describes the potential pathophysiological mechanisms associated with candidate CVD biomarkers. Future studies focused on these potential biomarkers and pathways will provide mechanistic clues of CVD pathogenesis and thus help with the risk assessment, diagnosis, and treatment of CVD.<\/jats:p>","DOI":"10.3390\/cells12242796","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T08:47:26Z","timestamp":1702025246000},"page":"2796","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-1683","authenticated-orcid":false,"given":"Dipali","family":"Kale","sequence":"first","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Fatangare","sequence":"additional","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9487-597X","authenticated-orcid":false,"given":"Prasad","family":"Phapale","sequence":"additional","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sickmann","sequence":"additional","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41569-020-0371-2","article-title":"Environmental determinants of cardiovascular disease: Lessons learned from air pollution","volume":"17","author":"Brook","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.99.9.1165","article-title":"Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14 786 middle-aged men and women in Finland","volume":"99","author":"Jousilahti","year":"1999","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kim, H., Kim, S., Han, S., Rane, P.P., Fox, K.M., Qian, Y., and Suh, H.S. (2019). Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: A nationwide population-based study. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-7439-0"},{"key":"ref_5","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142015 update: A report from the American Heart Association","volume":"134","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cjco.2021.10.003","article-title":"Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada from 2002 to 2018","volume":"4","author":"Mackinnon","year":"2022","journal-title":"CJC Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High Blood Pressure and Cardiovascular Disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12944-020-01204-y","article-title":"Dyslipidemia and cardiovascular disease risk among the MASHAD study population","volume":"19","author":"Hedayatnia","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/er.2018-00141","article-title":"Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents","volume":"40","author":"DeFronzo","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1185\/030079908X273372","article-title":"Serum lipid profiles and their relationship to cardiovascular disease in the elderly: The PREV-ICTUS study","volume":"24","author":"Lozano","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/ham.2010.1050","article-title":"Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet","volume":"12","author":"Sherpa","year":"2011","journal-title":"High Alt. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(84)90952-5","article-title":"Epidemiology of coronary heart disease: The Framingham study","volume":"76","author":"Castelli","year":"1984","journal-title":"Am. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: From plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: A Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Geyer, P.E., Holdt, L.M., Teupser, D., and Mann, M. (2017). Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol., 13.","DOI":"10.15252\/msb.20156297"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00508-019-1462-0","article-title":"Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2019): Common guideline of the Autrian Society for Bone and Mineral Research and the Austrian Diabetes Society","volume":"131","author":"Muschitz","year":"2019","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5414\/CPP41567","article-title":"Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials","volume":"41","author":"Vrecer","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.119.044282","article-title":"Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"ref_22","first-page":"CD009753","article-title":"Fibrates for primary prevention of cardiovascular disease events","volume":"11","author":"Jakob","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4093\/dmj.2020.0001","article-title":"Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2008.08.010","article-title":"Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get with The Guidelines","volume":"157","author":"Sachdeva","year":"2009","journal-title":"Am. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"713191","DOI":"10.3389\/fcvm.2021.713191","article-title":"Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients with Cardiovascular Disease","volume":"8","author":"Wong","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40246-018-0134-x","article-title":"Beyond genomics: Understanding exposotypes through metabolomics","volume":"12","author":"Rattray","year":"2018","journal-title":"Hum. Genom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for Investigating Physiological and Pathophysiological Processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1074\/mcp.M115.053702","article-title":"Simultaneous Metabolite, Protein, Lipid Extraction (SIMPLEX): A Combinatorial Multimolecular Omics Approach for Systems Biology","volume":"15","author":"Coman","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1194\/jlr.R067520","article-title":"Lipids, lysosomes, and autophagy","volume":"57","author":"Jaishy","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMra1104901","article-title":"The human plasma lipidome","volume":"365","author":"Quehenberger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Gallart-Ayala, H., Teav, T., and Ivanisevic, J. (2020). Metabolomics meets lipidomics: Assessing the small molecule component of metabolism. Bioessays, 42.","DOI":"10.1002\/bies.202000052"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wenk, M.R. (2016). Encyclopedia of Lipidomics, Springer.","DOI":"10.1007\/978-94-007-7864-1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.aca.2018.08.004","article-title":"Optimization of Folch, Bligh-Dyer, and Matyash sample-to-extraction solvent ratios for human plasma-based lipidomics studies","volume":"1037","author":"Ulmer","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chroma.2013.05.019","article-title":"Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography\/mass spectrometry","volume":"1298","author":"Chen","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"ref_36","first-page":"659","article-title":"Rapid Multi-Omics Sample Preparation for Mass Spectrometry","volume":"95","author":"Muehlbauer","year":"2023","journal-title":"Anal. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnmrs.2017.01.001","article-title":"Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics","volume":"100","author":"Marshall","year":"2017","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-021-00242-z","article-title":"Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI","volume":"9","author":"Andersen","year":"2021","journal-title":"Cancer Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jtos.2021.12.013","article-title":"In situ metabolic profile and spatial distribution of ocular tissues: New insights into dry eye disease","volume":"24","author":"Chen","year":"2022","journal-title":"Ocul. Surf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1039\/D1AY01940F","article-title":"Combining MALDI-MS with machine learning for metabolomic characterization of lung cancer patient sera","volume":"14","author":"Lai","year":"2022","journal-title":"Anal. Methods"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41467-021-27765-9","article-title":"Lipidomic profiling of human serum enables detection of pancreatic cancer","volume":"13","author":"Wolrab","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chroma.2017.01.040","article-title":"Recommendations for quantitative analysis of small molecules by matrix-assisted laser desorption ionization mass spectrometry","volume":"1486","author":"Wang","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jchromb.2011.01.028","article-title":"A GC-MS metabolic profiling study of plasma samples from mice on low- and high-fat diets","volume":"879","author":"Spagou","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"30.34.31","DOI":"10.1002\/0471142727.mb3004s114","article-title":"Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling","volume":"114","author":"Fiehn","year":"2016","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular Metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jgg.2017.02.004","article-title":"Metabolomics through the lens of precision cardiovascular medicine","volume":"44","author":"Lam","year":"2017","journal-title":"J. Genet. Genom."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.aca.2017.03.004","article-title":"Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry","volume":"966","author":"Wang","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15192","DOI":"10.1021\/acs.analchem.1c03905","article-title":"Simultaneous Analysis of the Metabolome and Lipidome Using Polarity Partition Two-Dimensional Liquid Chromatography\u2013Mass Spectrometry","volume":"93","author":"Feng","year":"2021","journal-title":"Anal. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1039\/C8AN01219A","article-title":"Merging metabolomics and lipidomics into one analytical run","volume":"144","author":"Schwaiger","year":"2018","journal-title":"Analyst"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jchromb.2008.04.031","article-title":"Analytical strategies for LC-MS-based targeted metabolomics","volume":"871","author":"Lu","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11306-016-0971-3","article-title":"Ion mobility mass spectrometry enhances low-abundance species detection in untargeted lipidomics","volume":"12","author":"Basit","year":"2016","journal-title":"Metabolomics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.analchem.2c03623","article-title":"Quantification of Dolichyl Phosphates Using Phosphate Methylation and Reverse-Phase Liquid Chromatography\u2013High Resolution Mass Spectrometry","volume":"95","author":"Kale","year":"2023","journal-title":"Anal. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1021\/acs.analchem.1c01751","article-title":"Isomer Selective Comprehensive Lipidomics Analysis of Phosphoinositides in Biological Samples by Liquid Chromatography with Data Independent Acquisition Tandem Mass Spectrometry","volume":"93","author":"Li","year":"2021","journal-title":"Anal. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1021\/acs.analchem.2c05192","article-title":"Ensuring Fact-Based Metabolite Identification in Liquid Chromatography\u2013Mass Spectrometry-Based Metabolomics","volume":"95","author":"Theodoridis","year":"2023","journal-title":"Anal. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/jasms.1c00311","article-title":"Systematic Optimization of Ambient Ionization Ion Mobility Mass Spectrometry for Rapid Separation of Isomers","volume":"33","author":"Olajide","year":"2022","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103828","DOI":"10.1016\/j.isci.2022.103828","article-title":"Impact of myocardial reperfusion on human plasma lipidome","volume":"25","author":"Surendran","year":"2022","journal-title":"iScience"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/CIA.S298743","article-title":"Quantitative Assessment of Serum Amino Acids and Association with Early-Onset Coronary Artery Disease","volume":"16","author":"Xuan","year":"2021","journal-title":"Clin. Interv. Aging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12944-020-01262-2","article-title":"U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study","volume":"19","author":"Xue","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhong, Z., Liu, J., Zhang, Q., Zhong, W., Li, B., Li, C., Liu, Z., Yang, M., and Zhao, P. (2019). Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China. Medicine, 98.","DOI":"10.1097\/MD.0000000000014309"},{"key":"ref_64","first-page":"649","article-title":"Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: The Prevenci\u00f3n con dieta mediterr\u00e1nea study","volume":"75","author":"Razquin","year":"2022","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"792350","DOI":"10.3389\/fcvm.2021.792350","article-title":"Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights","volume":"8","author":"Gander","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41467-022-28496-1","article-title":"Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology","volume":"13","author":"Wittenbecher","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"806819","DOI":"10.3389\/fendo.2021.806819","article-title":"Acetylcarnitine Is Associated with Cardiovascular Disease Risk in Type 2 Diabetes Mellitus","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056805","article-title":"Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation","volume":"146","author":"Eichelmann","year":"2022","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12944-021-01576-9","article-title":"Medium & long-chain acylcarnitine\u2019s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: A metabolomic study","volume":"20","author":"Zheng","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2021.01.059","article-title":"A plasma lipid signature predicts incident coronary artery disease","volume":"331","author":"Ottosson","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jamacardio.2019.4130","article-title":"Association of Circulating Metabolites with Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium","volume":"4","author":"Cavus","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"36162","DOI":"10.1039\/C9RA07634D","article-title":"Plasma fatty acid metabolic profiling coupled with clinical research reveals the risk factors for atherosclerosis development in type 2 diabetes mellitus","volume":"9","author":"Zhou","year":"2019","journal-title":"RSC Adv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ehf2.12453","article-title":"The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population","volume":"6","author":"Stenemo","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Lind, L., Salihovic, S., Sundstr\u00f6m, J., Broeckling, C.D., Magnusson, P.K., Prenni, J., Fall, T., and \u00c4rnl\u00f6v, J. (2021). Multicohort Metabolomics Analysis Discloses 9-Decenoylcarnitine to Be Associated with Incident Atrial Fibrillation. J. Am. Heart Assoc., 10.","DOI":"10.1161\/JAHA.120.017579"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, L., Yin, D., Zhou, Q., Lv, L., Dong, Z., and Shi, Y. (2022). Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure. BMC Genom., 23.","DOI":"10.1186\/s12864-022-09044-z"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"616081","DOI":"10.3389\/fcvm.2021.616081","article-title":"Plasma Metabolomics of Acute Coronary Syndrome Patients Based on Untargeted Liquid Chromatography\u2013Mass Spectrometry","volume":"8","author":"Zhong","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1210\/clinem\/dgac176","article-title":"Early Warning of Ischemic Stroke Based on Atherosclerosis Index Combined with Serum Markers","volume":"107","author":"Zhou","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s11010-021-04159-5","article-title":"Comprehensive plasma metabolomic and lipidomic analyses reveal potential biomarkers for heart failure","volume":"476","author":"Zhou","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12933-022-01568-8","article-title":"Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes","volume":"21","author":"Suvitaival","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/CIRCRESAHA.122.321253","article-title":"Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease","volume":"131","author":"Xue","year":"2022","journal-title":"Circ. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/s41467-022-29060-7","article-title":"Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2337\/dc21-1789","article-title":"Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies","volume":"45","author":"Shah","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12933-022-01716-0","article-title":"Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: Findings from the China Suboptimal Health Cohort","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.athplu.2021.09.005","article-title":"Assessment of plasma ceramides as predictor for subclinical atherosclerosis","volume":"45","author":"Mishra","year":"2021","journal-title":"Atheroscler. Plus"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2021.04.021","article-title":"Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies","volume":"327","author":"McGurk","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1007\/s00125-009-1482-9","article-title":"Link between plasma ceramides, inflammation and insulin resistance: Association with serum IL-6 concentration in patients with coronary heart disease","volume":"52","author":"Lankinen","year":"2009","journal-title":"Diabetologia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-011-9589-4","article-title":"Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome","volume":"41","author":"Majumdar","year":"2012","journal-title":"Endocrine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","article-title":"Plasma lipidomic analysis of stable and unstable coronary artery disease","volume":"31","author":"Meikle","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1161\/JAHA.117.007931","article-title":"Ceramide Remodeling and Risk of Cardiovascular Events and Mortality","volume":"7","author":"Peterson","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainresbull.2020.03.009","article-title":"Plasma levels of ceramides relate to ischemic stroke risk and clinical severity","volume":"158","author":"Gui","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lemaitre, R.N., Jensen, P.N., Hoofnagle, A., McKnight, B., Fretts, A.M., King, I.B., Siscovick, D.S., Psaty, B.M., Heckbert, S.R., and Mozaffarian, D. (2019). Plasma ceramides and sphingomyelins in relation to heart failure risk. Circ. Heart Fail., 12.","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction","volume":"3","author":"Tan","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"126925","DOI":"10.1172\/jci.insight.126925","article-title":"Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence","volume":"5","author":"Chew","year":"2019","journal-title":"JCI Insight"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/dme.13943","article-title":"Ceramides and diabetes mellitus: An update on the potential molecular relationships","volume":"37","author":"Yaribeygi","year":"2020","journal-title":"Diabet. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fendo.2019.00577","article-title":"The Role of Ceramides in Insulin Resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2014.10.007","article-title":"CerS2 Haploinsufficiency Inhibits \u03b2-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.1168532","article-title":"Protection of C. elegans from anoxia by HYL-2 ceramide synthase","volume":"324","author":"Menuz","year":"2009","journal-title":"Science"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1007\/s00216-016-9425-z","article-title":"Development and validation of a high-throughput LC-MS\/MS assay for routine measurement of molecular ceramides","volume":"408","author":"Kauhanen","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1007\/s00216-015-8585-6","article-title":"Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS\/MS","volume":"407","author":"Basit","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Huang, Q., Hao, S., Yao, X., You, J., Li, X., Lai, D., Han, C., Schilling, J., Hwa, K.Y., and Thyparambil, S. (2020). Quantitative LCMS for ceramides\/dihydroceramides: Pregnancy baseline biomarkers and potential metabolic messengers. bioRxiv.","DOI":"10.1101\/2020.02.24.963462"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Sigruener, A., Kleber, M.E., Heimerl, S., Liebisch, G., Schmitz, G., and Maerz, W. (2014). Glycerophospholipid and sphingolipid species and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085724"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma ceramides","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide stearic to palmitic acid ratio predicts incident diabetes","volume":"61","author":"Hilvo","year":"2018","journal-title":"Diabetologia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Lever, M., George, P.M., Slow, S., Bellamy, D., Young, J.M., Ho, M., McEntyre, C.J., Elmslie, J.L., Atkinson, W., and Molyneux, S.L. (2014). Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114969"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Lee, Y., Nemet, I., Wang, Z., Lai, H.T.M., de Oliveira Otto, M.C., Lemaitre, R.N., Fretts, A.M., Sotoodehnia, N., Budoff, M., and DiDonato, J.A. (2021). Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults. J. Am. Heart Assoc., 10.","DOI":"10.1161\/JAHA.120.020646"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"15580","DOI":"10.1038\/s41598-019-52082-z","article-title":"Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease","volume":"9","author":"Roncal","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2014.03.016","article-title":"Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry","volume":"455","author":"Wang","year":"2014","journal-title":"Anal. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"11647","DOI":"10.1038\/s41598-019-48246-6","article-title":"Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI","volume":"9","author":"Matsuzawa","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2021.09.026","article-title":"Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome","volume":"335","author":"Ringel","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/joim.13550","article-title":"Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease","volume":"292","author":"Dhar","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Tobias, D.K., Lawler, P.R., Harada, P.H., Demler, O.V., Ridker, P.M., Manson, J.E., Cheng, S., and Mora, S. (2018). Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women. Circ. Genom. Precis. Med., 11.","DOI":"10.1161\/CIRCGEN.118.002157"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12986-017-0195-1","article-title":"Free fatty acids and cardiovascular outcome: A Chinese cohort study on stable coronary artery disease","volume":"14","author":"Zhang","year":"2017","journal-title":"Nutr. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2013.10.036","article-title":"Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization","volume":"232","author":"Bhattacharya","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Li, S., Gao, D., and Jiang, Y. (2019). Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites, 9.","DOI":"10.3390\/metabo9020036"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fendo.2020.00617","article-title":"Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.4057","article-title":"A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance","volume":"22","author":"Jang","year":"2016","journal-title":"Nat. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/HCO.0000000000000552","article-title":"Altered branched chain amino acid metabolism: Toward a unifying cardiometabolic hypothesis","volume":"33","author":"Tobias","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_131","first-page":"1044","article-title":"Energy metabolism homeostasis in cardiovascular diseases","volume":"18","author":"Wang","year":"2021","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: A finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/4363","article-title":"Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation","volume":"20","author":"Wang","year":"2015","journal-title":"Front. Biosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1178646917691938","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jjcc.2008.12.007","article-title":"Inflammatory biomarkers in coronary artery disease","volume":"53","author":"Zakynthinos","year":"2009","journal-title":"J. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., and Chen, R. (2018). Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules, 8.","DOI":"10.3390\/biom8030080"},{"key":"ref_137","first-page":"768560","article-title":"Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease","volume":"12","author":"Halmi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","article-title":"The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)","volume":"71","author":"Siti","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tox.2007.12.023","article-title":"Strategic paths for biomarker qualification","volume":"245","author":"Goodsaid","year":"2008","journal-title":"Toxicology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11306-007-0070-6","article-title":"The metabolomics standards initiative (MSI)","volume":"3","author":"Fiehn","year":"2007","journal-title":"Metabolomics"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/acs.jproteome.1c00841","article-title":"Is Current Practice Adhering to Guidelines Proposed for Metabolite Identification in LC-MS Untargeted Metabolomics? A Meta-Analysis of the Literature","volume":"21","author":"Kodra","year":"2022","journal-title":"J. Proteome Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11306-014-0656-8","article-title":"Metabolite identification: Are you sure? And how do your peers gauge your confidence?","volume":"10","author":"Creek","year":"2014","journal-title":"Metabolomics"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: Communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.copbio.2018.07.010","article-title":"Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics","volume":"55","author":"Chaleckis","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Considine, E.C., and Salek, R.M. (2019). A Tool to Encourage Minimum Reporting Guideline Uptake for Data Analysis in Metabolomics. Metabolites, 9.","DOI":"10.20944\/preprints201901.0246.v1"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbalip.2017.02.016","article-title":"Common cases of improper lipid annotation using high-resolution tandem mass spectrometry data and corresponding limitations in biological interpretation","volume":"1862","author":"Koelmel","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-021-24984-y","article-title":"Quality control requirements for the correct annotation of lipidomics data","volume":"12","author":"Eichmann","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s42255-022-00628-3","article-title":"Introducing the Lipidomics Minimal Reporting Checklist","volume":"4","author":"McDonald","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell, V.B., FitzGerald, G.A., Murphy, R.C., Liebisch, G., Dennis, E.A., Quehenberger, O., Subramaniam, S., and Wakelam, M.J.O. (2020). Steps Toward Minimal Reporting Standards for Lipidomics Mass Spectrometry in Biomedical Research Publications. Circ. Genom. Precis. Med., 13.","DOI":"10.1161\/CIRCGEN.120.003019"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/24\/2796\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:29Z","timestamp":1760132129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/24\/2796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":150,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["cells12242796"],"URL":"https:\/\/doi.org\/10.3390\/cells12242796","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]}}}